Kenneth J. Hillan
Net Worth
Last updated:
What is Kenneth J. Hillan net worth?
The estimated net worth of Dr. Kenneth J. Hillan is at least $1,823,606 as of 24 Aug 2022. He owns shares worth $118,885 as insider, has earned $31,861 from insider trading and has received compensation worth at least $1,672,860 in 23andMe Holding Co..
What is the salary of Kenneth J. Hillan?
Dr. Kenneth J. Hillan salary is $557,620 per year as Head of Therapeutics in 23andMe Holding Co..
How old is Kenneth J. Hillan?
Dr. Kenneth J. Hillan is 64 years old, born in 1961.
What stocks does Kenneth J. Hillan currently own?
As insider, Dr. Kenneth J. Hillan owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| 23andMe Holding Co. (ME) | Head of Therapeutics | 196,083 | $0.61 | $118,885 |
What does 23andMe Holding Co. do?
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications based on genetic testing of a saliva sample through its spit kit. The Therapeutics segment focuses on the drug development; and discovery and development of novel therapies to improve patient lives across various therapeutic areas, including oncology, respiratory, and cardiovascular diseases, as well as offers out-licensing of intellectual property associated with identified drug targets related to drug candidates under clinical development. It has a collaboration agreement with GlaxoSmithKline Intellectual Property (No.3) Limited to leverage genetic insights to validate, develop, and commercialize drugs. The company was founded in 2006 and is headquartered in South San Francisco, California.
Kenneth J. Hillan insider trading
23andMe Holding Co.
Dr. Kenneth J. Hillan has made only one insider trade in 2022, according to the Form 4 filled with the SEC. He sold 8,753 units of ME stock worth $31,861 on 24 Aug 2022.
As of 24 Aug 2022 he still owns at least 196,083 units of ME stock.
23andMe Holding key executives
23andMe Holding Co. executives and other stock owners filed with the SEC:
- Dr. Kenneth J. Hillan (64) Head of Therapeutics
- Mr. Steven J. Schoch (66) Chief Financial and Accounting Officer
- Ms. Kathy L. Hibbs Esq., J.D. (61) Chief Legal & Regulatory Officer and Sec.